178 related articles for article (PubMed ID: 24291760)
1. Luminal epithelium in endometrial fragments affects their vascularization, growth and morphological development into endometriosis-like lesions in mice.
Feng D; Menger MD; Wang H; Laschke MW
Dis Model Mech; 2014 Feb; 7(2):225-32. PubMed ID: 24291760
[TBL] [Abstract][Full Text] [Related]
2. Differences in growth and vascularization of ectopic menstrual and non-menstrual endometrial tissue in mouse models of endometriosis.
Nenicu A; Yordanova K; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2021 Jul; 36(8):2202-2214. PubMed ID: 34109385
[TBL] [Abstract][Full Text] [Related]
3. In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy.
Laschke MW; Elitzsch A; Vollmar B; Menger MD
Fertil Steril; 2005 Oct; 84 Suppl 2():1199-209. PubMed ID: 16210012
[TBL] [Abstract][Full Text] [Related]
4. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
5. Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters.
Laschke MW; Schwender C; Vollmar B; Menger MD
Reprod Sci; 2010 Jun; 17(6):568-77. PubMed ID: 20332165
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions.
Feng D; Welker S; Körbel C; Rudzitis-Auth J; Menger MD; Montenarh M; Laschke MW
Angiogenesis; 2012 Jun; 15(2):243-52. PubMed ID: 22354315
[TBL] [Abstract][Full Text] [Related]
7. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling controls sprouting angiogenesis of endometriotic lesions.
Körbel C; Gerstner MD; Menger MD; Laschke MW
Angiogenesis; 2018 Feb; 21(1):37-46. PubMed ID: 28993956
[TBL] [Abstract][Full Text] [Related]
9. The ischemic time window of ectopic endometrial tissue crucially determines its ability to develop into endometriotic lesions.
Rudzitis-Auth J; Huwer SI; Scheuer C; Menger MD; Laschke MW
Sci Rep; 2022 Apr; 12(1):5625. PubMed ID: 35379836
[TBL] [Abstract][Full Text] [Related]
10. A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.
Edwards AK; Ramesh S; Singh V; Tayade C
Mol Hum Reprod; 2014 Oct; 20(10):1002-8. PubMed ID: 25024138
[TBL] [Abstract][Full Text] [Related]
11. A GFP endometriosis model reveals important morphological characteristics of the angiogenic process that govern benign and malignant diseases.
Machado DE; Palumbo A; Santos JM; Mattos RM; dos Santos TA; Seabra SH; Boldrini Lda C; Perini JA; Nasciutti LE
Histol Histopathol; 2014 Jul; 29(7):903-12. PubMed ID: 24385307
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
13. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.
Olivares CN; Alaniz LD; Menger MD; Barañao RI; Laschke MW; Meresman GF
PLoS One; 2016; 11(3):e0152302. PubMed ID: 27018976
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cyclooxygenase-2 Suppresses the Recruitment of Endothelial Progenitor Cells in the Microvasculature of Endometriotic Lesions.
Rudzitis-Auth J; Nickels RM; Menger MD; Laschke MW
Am J Pathol; 2018 Feb; 188(2):450-460. PubMed ID: 29154961
[TBL] [Abstract][Full Text] [Related]
18. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions.
Laschke MW; Giebels C; Nickels RM; Scheuer C; Menger MD
Am J Pathol; 2011 Jan; 178(1):442-50. PubMed ID: 21224081
[TBL] [Abstract][Full Text] [Related]
19. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
20. Cellular exchange in an endometriosis-adhesion model using GFP transgenic mice.
Wilkosz S; Pullen N; de-Giorgio-Miller A; Ireland G; Herrick S
Gynecol Obstet Invest; 2011; 72(2):90-7. PubMed ID: 21778678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
